Insider transactions

Christopher B Ehrlich

CIK 1293973 · Chairman and CEO · last filed 2026-01-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
37
Lifetime Open-Market Net
$8.09M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

BMTI price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
499 ILLINOIS STREET, SUITE 200
SAN FRANCISCO, CA 94158
Related Filers
Philip T Gianos — 8 joint filings, latest 2012-07-05
INTERWEST INVESTORS Q VIII LP — 7 joint filings, latest 2007-12-20
Douglas A Pepper — 7 joint filings, latest 2012-07-05
W Stephen Holmes — 6 joint filings, latest 2012-07-05
InterWest Management Partners VIII, LLC — 6 joint filings, latest 2006-03-31
Harvey B Cash — 5 joint filings, latest 2012-07-05
Linda Grais — 5 joint filings, latest 2010-08-10
Nina S Kjellson — 5 joint filings, latest 2012-07-05
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Chairman and CEO 5,795,408 $0.05 $290.3K $0 8 2026-01-09
eFFECTOR Therapeutics, Inc. (EFTRW) Delisted Director 177,381 $0.00 $106 $90.7K 13 2024-06-13
CERO THERAPEUTICS HOLDINGS, INC. (PBAXU) Delisted CEO and Secretary 699,996 $10.37 $7.26M $0 1 2021-10-12
LWACU See Remarks — $10.36 — $0 1 2021-01-14
BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Director 6,846 — — $8.00M 5 2009-04-08

Recent Filings · Page 4 of 4

37 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2010-01-19 — Grant (A) — $0
2009-04-08 BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Buy (P) +941,177 $8.00M EDGAR
2009-02-03 — Grant (A) +1,251,808 $0
2008-06-23 BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Grant (A) — $0 EDGAR
2008-06-20 BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Grant (A) — $0 EDGAR
2008-06-13 BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Grant (A) — $0 EDGAR
2007-06-25 BIOMIMETIC THERAPEUTICS, INC. (BMTI) Delisted Grant (A) — $0 EDGAR
Showing 31–37 of 37
Page 4 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.